The Geneticist Who Turned a Patient She Couldn't Help Into a Life's Work
Science·November 9, 2026
Marfan syndrome weakens the connective tissue that gives the body its structure, and the heart and major blood vessels are among the most exposed. Weakened walls can bulge into aneurysms, which can be fatal. The condition is inherited, so a person who has it has a 50/50 chance of passing it to each child, which makes it a family matter as much as a medical one.
For Dr Anne Child, a clinical geneticist, the condition became the focus of her working life. Born in Canada, she was working in Montreal when she met the British man she would later marry, a meeting she describes as love at first sight. In the 1970s she moved to the UK. Her direction was set by an encounter with a Marfan patient she was unable to help. That experience led her to build the team that identified the gene responsible for the disorder, and then to found the Marfan Trust so that research could continue beyond any single lab or grant.
Finding the gene matters in practice. Once the genetic cause is known, clinicians can test relatives who may have inherited the variant, catch problems earlier and set up monitoring before a dangerous aneurysm develops. Those changes, together with better treatment of the heart and blood vessels, have made a measurable difference. Life expectancy for people with Marfan syndrome was once around 32 years. It has since risen to more than 70.
In a conversation with Professor Jim Al-Khalili for The Life Scientific, Anne walks through how she and her colleagues achieved that turnaround, and what she thinks still needs to change.
Reporting based on an external source.